Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

Sai Parenteral Limited and Hella Infra Market have received final approval for their IPOs from Sebi. Sai Parenteral's ...

CDMOs are expanding to provide integrated services, enhancing outsourcing appeal. Sustainability mandates boost adoption of advanced systems, and growth is pronounced in excipient innovation and ...

New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of ...

Human Continuum Appoints Dr. Omar Khalid Sial, Ph.D., as its Chief Scientific Officer to Spearhead the Development of ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Drug development is an unforgiving business. Discovering a novel molecule is difficult enough, but then it can take years of preclinical studies and molecular tweaking to mitigate a drug’s toxicity, ...

Discover how iX Biopharma's patented drug delivery technology is driving its growth and expanding its product portfolio ...

The global pharmaceutical industry is witnessing a steady transformation as plant-based active pharmaceutical ingredients (APIs) move from complementary roles toward becoming core components in modern ...

Coating Place has appointed a new President, Ajay Damani, along with a new member of its Board of Directors, Rob Schrepfer.

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized ...